Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Investing With Purpose: Defiance Launches Autism Impact ETF

BY | ETF Database
06/03/2026 | 110 VIEWS
  • Related Symbols
  • ASD
With over 5,000 funds and many launching daily in the exchange-traded fund (ETF) universe, there are a select few that can capture both industrial utility and deep human significance. One of those ETFs launched with the introduction of the Defiance Autism Impact ETF (ASD) from Defiance ETFs — a leader in thematic and income-focused ETFs since 2018. Given its focus, the launch presents a milestone for the asset management community. ASD blends a sophisticated index design with structural corporate philanthropy to create an ETF that resonates with those invested financially and emotionally. “As a person, not just an ETF analyst, this makes me proud,” TMX VettaFi Head of Research Todd Rosenbluth wrote ahead of the launch, citing his own personal experience with an autistic family member. “While ETFs seem to launch on a daily basis, this one will be on my radar.” See more: Defiance ETFs’ Autism Impact Fund Filing Makes Me ProudInvestment StrategyThe Fund utilizes a passive indexing approach that tracks the total return performance of the VettaFi Autism Impact Index. This Index specifically targets publicly traded global companies in developed markets that support the autism and broader neurodivergent ecosystem. Eligible “Autism Impact Companies” must demonstrate material involvement across three core thematic pillars: drugs & behavior therapeutics, diagnostics & assessment tools, or specialized education & educational technology. More specifically, these companies include those that operate across healthcare, pharmaceuticals, biotechnology, behavioral services, diagnostics, specialized education, and assistive technologies. Constituents are screened according to public filings, revenue segmentations, and clinical trials. For inclusion in the Index, companies must maintain a minimum market capitalization of $250 million and a three-month average daily trading value of $1 million. The Index, which is equally weighted, is reconstituted semi-annually (in June and December) and rebalanced on a quarterly basis (March, June, September, and December).Supporting Neurodivergent CommunityThe fund notably features a voluntary impact-investing mandate that donates 100% of its net advisory profits during the first two years. After the two-year windows has expired, Defiance will continue donating at least 50% to support organizations involved in autism care, research, and neurodivergent resources. “As parents of a profoundly autistic child, this launch is deeply personal to our family,” said Matthew Bielski, CEO of Defiance ETFs, and Gabriella Zahn-Bielski, general counsel of Defiance ETFs. “Families impacted by autism face challenges every single day, and after experiencing that firsthand, we became committed to helping drive greater awareness, innovation, research, and support for the autism community. Our hope is that the ASD ETF can help direct more long-term capital and investment toward companies and organizations working to improve quality of life for individuals with autism and their families.” For more news, information, and analysis, visit the Thematic Investing Content Hub. VettaFi LLC (“VettaFi”) is the index provider for ASD which it receives an index licensing fee. However, ASD is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of ASD.

More Commentary

Score World Cup Investing Goals With This ETF
BY | ETF Database
7:19 am ET 06/10/26 | 23 VIEWS
XLU, XLP, XLRE: A Week in Review
BY | ETF Database
10:28 am ET 06/10/26 | 20 VIEWS
Financial Services Stocks Are Vexing Investors
BY | ETF Database
5:22 am ET 06/10/26 | 31 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.